1995
DOI: 10.1016/0163-7258(95)00012-6
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
505
1
18

Year Published

1999
1999
2016
2016

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 602 publications
(534 citation statements)
references
References 428 publications
10
505
1
18
Order By: Relevance
“…The accumulation of lipids in the steatotic liver may have produced a severe impairment of mitochondrial beta-oxidation of fatty acids, and thus microvesicular steatosis as proposed by Fromenty and Pessayre (1995). Microvesicular steatosis has been reported in other pathologic conditions of ewes affecting mitochondrial metabolism, such as cobalt deficiency (Kennedy et al, 1997).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The accumulation of lipids in the steatotic liver may have produced a severe impairment of mitochondrial beta-oxidation of fatty acids, and thus microvesicular steatosis as proposed by Fromenty and Pessayre (1995). Microvesicular steatosis has been reported in other pathologic conditions of ewes affecting mitochondrial metabolism, such as cobalt deficiency (Kennedy et al, 1997).…”
Section: Resultsmentioning
confidence: 99%
“…Microvesicular steatosis has been reported in other pathologic conditions of ewes affecting mitochondrial metabolism, such as cobalt deficiency (Kennedy et al, 1997). Similarly, acute fatty liver during late pregnancy in humans is characterized by microvesicular steatosis (Fromenty and Pessayre, 1995;Burt, 2001). The mild steatotic changes observed in the liver of ewes that recovered from pregnancy toxemia, suggests that fatty liver with microvesicular steatosis can be reversed if treated.…”
Section: Resultsmentioning
confidence: 99%
“…The main adverse effects of amiodarone include hypotension, thyroid toxicity (hyper‐ or hypothyroidism), pulmonary toxicity including bronchiolitis and pulmonary fibrosis, and hepatic lesions such as steatosis, steatohepatitis, and cirrhosis (Dusman et al. 1990; Fromenty and Pessayre 1995; Santangeli et al. 2012).…”
Section: Introductionmentioning
confidence: 99%
“…2012). Numerous studies have shown that mitochondrial dysfunction is a major mechanism of amiodarone‐induced toxicity in liver and other tissues (Fromenty and Pessayre 1995; Di Matola et al. 2000; Nicolescu et al.…”
Section: Introductionmentioning
confidence: 99%
“…25 The side chain is metabolized by ␤-oxidation, leading to inhibition of medium-and short-chain fatty acid ␤-oxidation. 26,45 Thus, both drugs are converted by P450 to reactive metabolites that can induce a hypersensitivity reaction in genetically susceptible individuals. Less commonly, they induce a microvesicular steatosis; in mice, this requires much higher doses than those used therapeutically, 27 although one wonders if impaired oxidation of these drugs (in the presence of a competing P450 substrate or in a poor metabolizer) might lead, at least rarely, to the accumulation of sufficient levels of the parent drug to impair ␤-oxidation.…”
Section: Antidepressantsmentioning
confidence: 99%